6-Attachment B - Scope of Work.docx

Attachment B: Scope of Work Chronic Disease Prevention Partnership 2026

Article 1

DEFINITIONS

1.1 Definitions. In this contract, the following definitions apply:

“B&C” means the Utah Breast and Cervical Cancer Program.

“B&C Bars” means the DHHS online data portal.

“EBI” means Evidence Based Interventions.

“Health Center” means a health clinic that receives Health Center Program funding under Section 330 of the Public Health Service Act or community-based health care providers that officially meet all program requirements of the HRSA Health Center Program, but do not receive Health Center Program funding.

“Health Systems” means Health Center and Allied Health Care Organizations.

“Quit Service” means Utah Tobacco and Nicotine Quit Services.

“TPCP” means the Tobacco Prevention and Control Program.

“UDS” means Uniform Data System.

Article 2

SERVICE REQUIREMENTS

2.1 TPCP Activities. The Contractor shall:

(1) provide training to selected Health Centers and affiliates on the following projects:

(A) Tobacco Cessation Medications for the Uninsured (bupropion and varenicline);

(B) Tobacco Use: Screening and Cessation Intervention UDS requirement; and

(C) Adolescent Vape Project, a pilot project to improve adolescent vaping cessation outcomes;

(2) update materials for the Tobacco Cessation Medications for the Uninsured Program;

(3) conduct surveillance data reviews on the following:

(A) UDS measure reports (annually);

(B) Quit Service enrollment reports (quarterly); and

(C) Health Center pharmacy-transaction reports (annually);

(4) serve as a communication liaison between Health Centers and the Huntsman Center for HOPE staff and provide updates twice a year to local health department tobacco cessation teams; and

(5) submit quarterly progress reports and an annual report on the success of tobacco cessation activities to DHHS.

2.2 B&C Activities. The Contractor shall:

(1) evaluate B&C screening in participating Health Systems for evidence-based interventions;

(A) analyze annual rates using Azara, a population health management tool, or other population health tools;

(B) assess training and technical assistance needs for each participating Health System;

(C) provide best practices to optimize clinical and digital breast and cervical screening workflows using:

(i) the UDS measures for evidence-based processes;

(ii) patient reminder method/system; patient outreach tools such as patient portals and/or simplifying language used in patient outreach tools; and

(iii) provider outreach tools such as patient visit planning for provider reminders, data validation, registries, score cards, risk stratification, and patient registries;

(D) provide teaching and technical assistance on implementing best practices to optimize scheduling workflows and follow-up for completion of breast and cervical cancer screening by using:

(i) care gap workflows and quality improvement tools and processes such as Plan-Do-Study-Act; Assess, Implement, and Measure statement;

(ii) clinic provided patient navigation through individualized assistance to clients; and/or

(iii) a screening and referral process for health needs or the conditions and the environments where people are born, live, work, play, worship, and age.

(2) use patient education and/or small media to close identified care gaps with Health Systems by using:

(A) current American Cancer Society education videos and/or Huntsman Cancer Hospital resources;

(B) Health System and Huntsman Cancer Hospital pilot program for self-collected testing to assist in closing cervical cancer screening gaps;

(C) a library of on-demand reference materials for providers and clinics; and

(D) a health educator or clinical staff to provide patient education.

(3) Reports. All Health System clinic locations not currently participating in the project must complete a baseline enrollment information report for B&C bars before enrolling in the EBI project and sent to the B&C by May 30th of each year:

(A) submit annual data for B&C bars and sent to B&C by August 30th of each year; and

(B) enter quarterly progress information in the B&C excel spreadsheet.

Article 3

FUNDING

3.1 TPCP funding.

(a) $85,000.00 for the period July 1, 2026 to June 30, 2027.

(b) $85,000.00 for the period July 1, 2027 to June 30, 2028.

(c) $85,000.00 for the period July 1, 2028 to June 30, 2029.

(d) $85,000.00 for the period July 1, 2029 to June 30, 2030.

(e) $85,000.00 for the period July 1, 2030 to June 30, 2031.

3.2 B&C funding.

(a) $45,000.00 for the period July 1, 2026 to June 30, 2027.

(b) $45,000.00 for the period July 1, 2027 to June 30, 2028.

(c) $45,000.00 for the period July 1, 2028 to June 30, 2029.

(d) $45,000.00 for the period July 1, 2029 to June 30, 2030.

(e) $45,000.00 for the period July 1, 2030 to June 30, 2031.

Article 4

OUTCOMES

4.1 Outcomes.

(1) The TPCP desired outcome is increased access to tobacco cessation interventions for Health Center patients.

(2) The B&C desired outcome is to increase the use of EBI’s in each participating Health System in order to increase breast and cervical cancer screening:

(B) Measure: Number of participating Health Systems that received EBI assistance to increase cervical cancer screening;

Expected Standard: 13

4.2 Reporting. The Contractor shall complete reports as outlined in the service requirements.